Catalent, Inc. is specialized in pharmaceutical outsourcing services. The group offers solutions for the development and formulation of drugs, biological products and animal health products. Net sales break down by activity as follows: – subcontracted manufacturing services (48.5%) – provision of development services (43.2%); – clinical supply services (8.3%). Net sales are distributed geographically as follows: the United States (62.9%), Europe (30.5%) and other (6.6%).
Source: marketscreener.com
